SmithKline HQ sale on hold

18 June 1999

The pharmaceuticals company had been about to sign a deal with the Schroder, Stanhope and Bovis consortium, but decided last week that it would fund and develop the 72,460 sq m (779,970 sq ft) office scheme itself.

This content is only available to registered users

You must be logged in to continue

Would you like to read more?

Try Property Week For Free to finish this article.

Unlimited access to Property Week
Breaking news, comment and analysis from industry experts as it happens
Choose from our portfolio of email newsletters

To access this article TRY FOR FREE NOW

Don’t want full access? REGISTER NOW to read this article and up to 3 more this month and subscribe to our newsletters.

Registered users and subscribers SIGN IN here to continue